The IVO-LUNG Study

NCT07204548 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer (Stage III)

Interventions

DRUG: Ivonescimab

Sponsor

Sun Yat-sen University